AP-001(Anida)

N/A

Report date: 2023/03/12 17:04:07
NME

Base Information

Drug NameAP-001(Anida)
Drug Alias Nameneuroprotectin D1AP-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinopathy of PrematurityMacular DegenerationRetinitis Pigmentosa +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnida Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnida Pharma Inc
Inactive CompaniesN/A
Active IndicationsRetinopathy of PrematurityMacular DegenerationRetinitis Pigmentosa +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A